Mark Brönstrup has been head of the Department of Chemical Biology at the Helmholtz Centre for Infection Research and since 2013 he has also held a Professorship at the Leibniz Universität Hannover.
After his graduation, he worked as a laboratory head for Mass Spectrometry at Aventis. This was complemented by a research sabbatical in 2003 at Harvard Medical School. He then led the Natural Product Sciences section at Sanofi-Aventis in Frankfurt with the goal of discovering leads from natural sources and optimising them to clinical candidates. He dealt with translational research projects from 2010 to 2013 as a section head for Biomarkers & Diagnostics in the Diabetes Division and a domain head for Biomarkers, Bioimaging & Biological Assays at Sanofi. His research is focused on the discovery and the characterization of novel anti-infective drugs. This also includes the establishment of novel analytical and diagnostic methods
Mark studied Chemistry at Philipps-Universität Marburg in Germany and at Imperial College London in the UK. In 1999 he received his doctorate from the Technical University Berlin in Organic Chemistry.